cinacalcet has been researched along with Anemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Micozkadioglu, H; Nursal, GN; Ozelsancak, R; Torun, D; Yigit, F; Yildiz, I | 1 |
| Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Ito, K; Matsushita, K; Tanaka, M; Yoshida, K | 1 |
| Erickson, KF; Winkelmayer, WC | 1 |
| Okimoto, N; Oshiro, Y; Tanaka, H | 1 |
| Bargman, JM; Battistella, M; Chan, CT; Richardson, RM | 1 |
| Cases, A | 2 |
1 review(s) available for cinacalcet and Anemia
| Article | Year |
|---|---|
Update in nephrology. Highlights from the 36th Annual Meeting of the American Society of Nephrology.
Topics: Anemia; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Congresses as Topic; Diabetic Nephropathies; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Nephrology | 2004 |
6 other study(ies) available for cinacalcet and Anemia
| Article | Year |
|---|---|
The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism.
Topics: Anemia; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Pilot Projects; Prospective Studies; Renal Dialysis | 2016 |
Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.
Topics: Aged; Anemia; Calcimimetic Agents; Calcitriol; Case-Control Studies; Cinacalcet; Diabetes Complications; Female; Follow-Up Studies; Glomerulonephritis; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Parathyroid Hormone; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome | 2016 |
The challenges of cost-effectiveness analyses for the clinician.
Topics: Anemia; Cinacalcet; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematinics; Hemoglobins; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Naphthalenes; Quality-Adjusted Life Years; Renal Dialysis; Vitamin D | 2010 |
A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet.
Topics: Anemia; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis | 2011 |
Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease.
Topics: Anemia; Cinacalcet; Cohort Studies; Darbepoetin alfa; Drug Interactions; Erythropoietin; Female; Hematinics; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2011 |
The latest findings in basic and clinical nephrology science.
Topics: Anemia; Cinacalcet; Clinical Trials as Topic; Humans; Kidney Diseases; Kidney Transplantation; Lanthanum; Naphthalenes; Renal Dialysis | 2005 |